- PII
- S3034511125060043-1
- DOI
- 10.7868/S3034511125060043
- Publication type
- Article
- Status
- Published
- Authors
- Volume/ Edition
- Volume 525 / Issue number 1
- Pages
- 44-54
- Abstract
- The paper presents approaches to the synthesis of ether derivatives of the antiparkinsonian agent Prottremine ((1,2,6)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol) at positions 1 and 9. The synthesis of the 1-methoxy derivative was carried out by isomerization of verbenol epoxide methyl ether on K10 montmorillonite clay with a yield of 31%. The synthesis of 9-MeO-, 9--PrO- and 9--BuO-derivatives was developed on the basis of the 9-Br-derivative by sequential introduction of methoxymethyl protection, interaction with the corresponding alcoholates and removal of the protecting groups. The yield of the target compounds in three steps was 40–59%.
- Keywords
- Проттремин терпен простые эфиры метоксиметильная защита изомеризация болезнь Паркинсона
- Date of publication
- 01.01.2026
- Year of publication
- 2026
- Number of purchasers
- 0
- Views
- 54
References
- 1. De Alvarenga J.F.R., Genaro B., Costa B.L., Purgatto E., Manach C., Fiamoncini J. Crit. Rev. Food Sci. Nutr. 2023. V. 63. № 10. P. 1352–1389. https://doi.org/10.1080/10408398.2021.1963945
- 2. De Sousa D.P., de Assis Oliveira F., Arcanjo D.D. R., da Fonsêca D.V., Duarte A.B.S., de Oliveira Barbosa C., Ong T.P., Brocksom T.J. Biomedicines. 2024. V. 12. № 1185. https://doi.org/10.3390/biomedicines12061185
- 3. Chauhan D., Bagri K., Deshmukh R. Eur. J. Pharmacol. 2025. V. 996. № 177558. https://doi.org/10.1016/j.ejphar.2025.177558
- 4. Wojtunik-Kulesza K.A., Rudkowska M., Klimek K., Mołdoch J., Agacka-Mołdoch M., Budzyńska B., Oniszczuk A. Molecules. 2024. V. 29. P. 4365. https://doi.org/10.3390/molecules29184365
- 5. Hadipour E., Shahangian S.Sh., Mashayekhi F. Caspian J. Neurol. Sci. 2024. V. 10. № 1. P. 1–19. https://doi.org/10.32598/CJNS.10.36.460.1
- 6. Shamsi A., Shahwan M., Furkan M., Khan M.S., Yadav D.K., Khan R.H. Heliyon. 2024. V. 10. e32755. https://doi.org/10.1016/j.heliyon.2024.e32755
- 7. Tan X., Xu R., Li A.-P., Li D., Wang Y., Zhao Q., Long L.-P., Fan Y.-Z., Zhao C.-X., Liu Y., Li S.-H. Biomed. Pharmacother. 2024. V. 175. P. 116784. https://doi.org/10.1016/j.biopha.2024.116784
- 8. Singh R., Kaur N., Dhingra N., Kaur T. Neurochem. Int. 2024. V. 177. P. 105762. https://doi.org/10.1016/j.neuint.2024.105762
- 9. Foroughi S., Shahanipour K., Monajemi R., Ahadi A.M. Brain Res. 2024. V. 1838. P. 148966. https://doi.org/10.1016/j.brainres.2024.148966
- 10. An F., Bai Y., Xuan X., Bian M., Zhang G., Wei C. Molecules. 2022. V. 27. P. 3913. https://doi.org/10.3390/molecules27123913
- 11. Khan-Mohammadi-Khorrami M.K., Asle-Rousta M., Rahnema M., Amini R. J. Biochem. Mol. Toxicol. 2022. V. 36. Р. e23006. https://doi.org/10.1002/jbt.23006
- 12. Eddin L.B., Jha N.K., Meeran M.F.N., Kesari K.K., Beiram R., Ojha S. Molecules. 2021. V. 26. P. 4535. https://doi.org/molecules26154535
- 13. Wojtunik-Kulesza K., Rudkowska M., Kasprzak-Drozd K., Oniszczuk A., Borowicz-Reutt K. Int. J. Mol. Sci. 2021. V. 22. P. 7366. https://doi.org/10.3390/ijms22147366
- 14. Habotta O.A., Saad Ali L., Kassab R.B., Zhang Q., Zheng M., Alrashdi B.M., Tayyeb J.Z., Jawi M., Elhefny M.A., Al Sberi H., Abd-Eldaim D., Abdelbagi O., Lokman M.S. J. Agric. Food Res. 2025 V. 22 P. 101993. https://doi.org/10.1016/j.jafr.2025.101993
- 15. Chinnappan D., Krishnan M., Kuppamuthu A., Elangovan N. Neurochem. Res. 2025. V. 50. P. 158. https://doi.org/10.1007/s11064-025-04407-w
- 16. Hu X., Yan Y., Liu W., Liu J., Fan T., Deng H., Cai Y. Phytomedicine. 2024. V. 132. P. 155848. https://doi.org/10.1016/j.phymed.2024.155848
- 17. Ding L., Wang L., Yang J., Jiang C., Sun X., Huang H., Zhan X., Liu F., Zhang Q. ACS Chem. Neurosci. 2024. V. 15. № 11. P. 2308–2321. https://doi.org/10.1021/acschemneuro.4c00139
- 18. Chang W.-H., Hsu H.-T. Lin C.-C., An L.-M., Lee C.-H., Ko H.-H., Lin C.-L., Lo Y.-C. Int. J. Mol. Sci. 2024. V. 25. P. 2514. https://doi.org/10.3390/ijms25052514
- 19. Esmaealzadeh D., Moodi Ghalibaf A.A., Shariati Rad M., Rezaee R., Razavi B. M., Hosseinzadeh H. Iran. J. Basic Med. Sci. 2023. V. 26. P. 1131–1143. https://dx.doi.org/10.22038/IJBMS.2023.69824.15197
- 20. Rekha K.R., Selvakumar G.P., Santha K., Inmozhi Sivakamasundari R. Biochem. Biophys. Res. Commun. 2013. V. 440. P. 664–670. http://dx.doi.org/10.1016/j.bbrc.2013.09.122
- 21. Javed H., Fizur N.M.M., Jha N.K., Ashraf G.Md., Ojha S. Curr. Neuropharmacol. 2023. V. 21. № 6. P. 1421–1432. https://doi.org/10.2174/1570159X21666221223120251
- 22. Eddin L.B., Azimullah S., Jha N.K., Nagoor Meeran M.F., Beiram R., Ojha S. Int. J. Mol. Sci. 2023. V. 24. P. 5222. https://doi.org/10.3390/ijms24065222
- 23. Azimullah S., Jayaraj R.L., Meeran M.F.N., Jalal F.Y., Adem A., Ojha S., Beiram R. Molecules. 2023. V. 28. P. 685. https://doi.org/10.3390/molecules28020685
- 24. Ahmed S., Panda S.R., Kwatra M., Sahu B.D., Naidu V.G.M. ACS Chem. Neurosci. 2022. V. 13. P. 53−68. https://doi.org/10.1021/acschemneuro.1c00550
- 25. Silva-Martins S., Beserra-Filho J.I.A., Maria-Macêdo A., Custódio-Silva A.C., Soares-Silva B., Silva S.P., Lambertucci R.H., Silva R.H., Dos Santos J.R., Gandhi S. R., Quintans-Júnior L.J., Ribeiro A.M. Clin. Exp. Pharmacol. Physiol. 2021. V. 48. № 11. P. 1488–1499. https://doi.org/10.1111/1440-1681.13563
- 26. Anis E., Zafeer M.F., Firdaus F., Islam S.N., Khan A.A., Hossain M.M. Neurotoxic. Res. 2020. V. 38. P. 461–477. https://doi.org/10.1007/s12640-020-00213-0
- 27. De Lucena J.D., Gadelha-Filho C.V.J., da Costa R.O., de Araújo D.P., Viana Lima F.A., Tavares Neves K.R., De Barros Viana G.S. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2020. V. 393. P. 1077–1088. https://doi.org/10.1007/s00210-019-01793-1
- 28. Il’ina I.V., Volcho K.P., Korchagina D.V., Barkhash V.A., Salakhutdinov N.F. Helv. Chim. Acta. 2007. V. 90. № 2. P. 353–368. https://doi.org/10.1002/hlca.200790042
- 29. Ardashov O.V., Pavlova A.V., Il’ina I.V., Morozova E.A., Korchagina D.V., Karpova E.V., Volcho K.P., Tolstikova T.G., Salakhutdinov N.F. J. Med. Chem. 2011. V. 54. № 11. P. 3866–3874. https://doi.org/10.1021/jm2001579
- 30. Valdman E., Kapitsa I., Ivanova Е., Voronina T., Ardashov O., Volcho K., Khazanov V., Salakhutdinov N. Eur. J. Pharmacol. 2017. V. 815. P. 351–363. https://doi.org/10.1016/j.ejphar.2017.09.022
- 31. GRLSBASE: https://grlsbase.ru/clinicaltrails/clintrail/581. Ссылка активна на 03.07.2025.
- 32. Ardashov O.V., Pavlova A.V., Mahato A.K., Sidorova Yu., Morozova E.A., Korchagina D.V., Salnikov G.E., Genaev A.M., Patrusheva O.S., Li-Zhulanov N.S., Tolstikova T.G., Volcho K.P., Salakhutdinov N.F. ACS Chem. Neurosci. 2019. V. 10. № 10. P. 4337–4349. https://doi.org/10.1021/acschemneuro.9b00396
- 33. Ardashov O.V., Pavlova A.V., Korchagina D.V., Volcho K.P., Tolstikova T.G., Salakhutdinov N.F. Bioorg. Med. Chem. 2013. V. 21. № 5. P. 1082–1087. https://doi.org/10.1016/j.bmc.2013.01.003
- 34. Kotlyarova A., Podturkina A.V., Pavlova A.V., Gorina D.S., Lastovka A.V., Ardashov O.V., Rogachev A.D., Izyurov A.E., Arefieva A.B., Kulikov A.V., Tolstikova T.G., Volcho K.P., Salakhutdinov N.F., Sidorova Yu. Molecules. 2022. V. 27. P. 8286. https://doi.org/10.3390/molecules27238286
- 35. Подтуркина А.В., Ардашов О.В., Павлова А.В., Толстикова Т.Г., Волчо К.П., Салахутдинов Н.Ф. 2-((1-(4R-Бензил)-1H-1,2,3-триазол-4-ил)метокси)-3-метил-6-(проп-1-ен-2-ил)циклогекс-3-ен-1-ол в качестве противопаркинсонического средства. Патент РФ № 2812081 C1. 2024.
- 36. Buendia J., Chang Z., Eijsberg H., Guillot R., Frongia A., Secci F., Xie J., Robin S., Boddaert T., Aitken D. Angew. Chem. Int. Ed. 2018 V. 57. № 22. P. 6592–6596. https://doi.org/10.1002/anie.201803571
- 37. Nicolaou K.C., Yu R., Lu Z., Alvarez F.G. J. Am. Chem. Soc. 2022. V. 144. № 11. P. 5190−5196. https://doi.org/10.1021/jacs.2c01305
- 38. Podturkina A.V., Ardashov O.V., Soldatova Yu.V., Poletaeva D.A., Smolina A.V., Vasyuchenko E.P., Vyatkin Yu.V., Li-Zhulanov N.S., Faingold I.I., Salakhutdinov N.F., Volcho K.P. Int. J. Mol. Sci. 2025. V. 26. P. 97. https://doi.org/10.3390/ijms26010097